Evidence map›Paper›PMID 36647394›Full record

ReviewHeliyon2023

The medicinal value of tea drinking in the management of COVID-19.

Jiaming Ge, Tianbao Song, Mengyuan Li, Weisan Chen, Jiarong Li, Sihan Gong, Ying Zhao, Lin Ma, Hongjian Yu, Xiankuan Li and 1 more

Open access · goldAbstract readReview
In one paragraph

Review in Heliyon, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
3.1field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 1 institution in 1 country.

Jiaming GeTianjin University of Traditional Chinese Medicine, 301617, Tianjin, China.
Tianbao SongTianjin University of Traditional Chinese Medicine, 301617, Tianjin, China.
Mengyuan LiTianjin University of Traditional Chinese Medicine, 301617, Tianjin, China.
Weisan ChenTianjin University of Traditional Chinese Medicine, 301617, Tianjin, China.
Jiarong LiTianjin University of Traditional Chinese Medicine, 301617, Tianjin, China.
Sihan GongTianjin University of Traditional Chinese Medicine, 301617, Tianjin, China.
Ying ZhaoTianjin University of Traditional Chinese Medicine, 301617, Tianjin, China.
Lin MaTianjin University of Traditional Chinese Medicine, 301617, Tianjin, China.
Hongjian YuWuxi Century Bioengineering Co., Ltd., Wuxi 214000, China.
Xiankuan LiTianjin University of Traditional Chinese Medicine, 301617, Tianjin, China.
Kun FuSecond Teaching Hospital of Tianjin University of Traditional Chinese Medicine, 300120, Tianjin, China.
Tianjin University of Traditional Chinese Medicine · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Corona Virus Disease 2019 (COVID-19) is presently the largest international public health event, individuals infected by the virus not only have symptoms such as fever, dry cough, and lung infection at the time of onset, but also possibly have sequelae in the cardiovascular system, respiratory system, nervous system, mental health and other aspects. However, numerous studies have depicted that the active ingredients in tea show good antiviral effects and can treat various diseases by regulating multiple pathways, and the therapeutic effects are associated with the categories of chemical components in tea. In this review, the differences in the content of key active ingredients in different types of tea are summarized. In addition, we also highlighted their effects on COVID-19 and connected sequelae, further demonstrating the possibility of developing a formulation for the prevention and treatment of COVID-19 and its sequelae through tea extracts. We have a tendency to suggest forestalling and treating COVID-19 and its sequelae through scientific tea drinking.

Indexed as

COVID-19Network pharmacologySequelaeTea

Identifiers

PMID36647394
PMCPMC9833859
OpenAlexW4315628709

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.